Novartis Wins Top Share Of HHS’ Initial Pandemic Flu Vaccine Contracts
Three large companies will get the lion's share of the federal government's first $1 billion in spending on development of vaccine for the emerging novel strain of influenza
Three large companies will get the lion's share of the federal government's first $1 billion in spending on development of vaccine for the emerging novel strain of influenza